Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-011690

CHIEF FINANCIAL OFFICER sold 88,395 shares at an average $26.56 ($2,347,335)

  • CHIEF FINANCIAL OFFICER acquired 88,395 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-29 Option exercise 10b5-1 +20,000 $15.52 $310,400 47,009 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-29 Option exercise 10b5-1 +22,000 $15.50 $341,000 69,009 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-29 Sale 10b5-1 −42,000 $25.61 $1,075,620 27,009 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-30 Option exercise 10b5-1 +21,254 $16.90 $359,193 48,263 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-30 Sale 10b5-1 −21,254 $26.95 $572,795 27,009 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Option exercise 10b5-1 +12,000 $17.92 $215,040 39,009 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Option exercise 10b5-1 +13,141 $17.76 $233,384 52,150 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Sale 10b5-1 −25,141 $27.80 $698,920 27,009 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-29 Option exercise · Share Option 10b5-1 −20,000 0 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-29 Option exercise · Share Option 10b5-1 −22,000 0 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-30 Option exercise · Share Option 10b5-1 −21,254 2,471 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Option exercise · Share Option 10b5-1 −12,000 0 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-05-01 Option exercise · Share Option 10b5-1 −13,141 28,909 D
Open-market sales · 88,395 sh · avg $26.56 · $2,347,335
Loading xslF345X05/form4-05012025_100529.xml…